Vaporox

10:45 AM - 11:00 AM (EDT), Wednesday, October 23, 2019 ・ 2nd Floor
Vaporox, Inc.’s Vaporous Hyperoxia Therapy (VHT™), a patented, and FDA-510K-cleared technology, offers a breakthrough in treating 9 different types of skin wounds, including diabetic foot ulcers (DFUs).

Clinical trial data has shown that VHT can heal 70% or more of DFUs that have previously resisted standard wound care treatment, and at a much lower cost than less effective methods.
Company Type:
Company Website:
Company HQ State:
Colorado
Company HQ Country:
United States
Year Founded:
2016
Main Therapeutic Focus:
Lead Product in Development:
Loren Hutchins
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
One